Mouse Anti-FBXL7 Recombinant Antibody (CBXF-0388) (V2LY-0925-LY407)

Wang, Y., Shen, X., Gong, L., Zhao, Y., & Xiong, X. (2022). Functional characterization of FBXL7 as a novel player in human cancers. Cell Death Discovery, 8(1), 1-8.

Camuzi, D., Buexm, L. A., Lourenço, S. D. Q. C., Grazziotin, R., Guaraldi, S., Valverde, P., ... & Soares-Lima, S. C. (2022). FBXL7 body hypomethylation is frequent in tumors from the digestive and respiratory tracts and is associated with risk-factor exposure. International Journal of Molecular Sciences, 23(14), 7801.

Ni, J., Shen, L., Xu, L., Jin, Q., & Wang, G. (2021). 7-Ethoxyrosmanol alleviates hyperglycemia-induced vascular endothelial dysfunction by regulating FBXL7 expression. Journal of Bioenergetics and Biomembranes, 53(5), 553-560.

Moro, L., Simoneschi, D., Kurz, E., Arbini, A. A., Jang, S., Guaragnella, N., ... & Pagano, M. (2020). Epigenetic silencing of the ubiquitin ligase subunit FBXL7 impairs c-SRC degradation and promotes epithelial-to-mesenchymal transition and metastasis. Nature cell biology, 22(9), 1130-1142.

Boone, P. M., Paterson, S., Mohajeri, K., Zhu, W., Genetti, C. A., Tai, D. J., ... & Rodan, L. H. (2020). Biallelic mutation of FBXL7 suggests a novel form of Hennekam syndrome. American Journal of Medical Genetics Part A, 182(1), 189-194.

Kong, S., Fang, Y., Wang, B., Cao, Y., He, R., & Zhao, Z. (2020). miR‐152‐5p suppresses glioma progression and tumorigenesis and potentiates temozolomide sensitivity by targeting FBXL7. Journal of Cellular and Molecular Medicine, 24(8), 4569-4579.

Moro, L., & Pagano, M. (2020). Epigenetic suppression of FBXL7 promotes metastasis. Molecular & Cellular Oncology, 7(6), 1833698.

Chiu, H. W., Chang, J. S., Lin, H. Y., Lee, H. H., Kuei, C. H., Lin, C. H., ... & Lin, Y. F. (2018). FBXL7 upregulation predicts a poor prognosis and associates with a possible mechanism for paclitaxel resistance in ovarian cancer. Journal of clinical medicine, 7(10), 330.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols